Navigation Links
NYSE Amex Required Update
Date:8/29/2011

ANNAPOLIS, Md., Aug. 29, 2011 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that in view of the relatively large increase in the price of its stock at the end of the trading day on August 25, 2011, the NYSE Amex has contacted the Company in accordance with its usual practice.  It is the Company's policy not to comment on market rumors. However, in compliance with  NYSE Amex listing requirements and at the Exchange's direction, the Company confirms that at the time of this release, it has not received from the Court of Chancery of Delaware a decision relating to the pending litigation with Siga Technologies, Inc. or any additional specific information relating to the timing thereof.

Statement on Cautionary Factors

Except for the historical information presented herein, matters discussed may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "potential"; "believe"; "anticipate"; "intend"; "plan"; "expect"; "estimate"; "could"; "may"; "should"; or similar statements are forward-looking statements. PharmAthene disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risk associated with the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of the Company's product candidates, unexpected funding delays and/
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Safety in Drinking Water? Monitoring for Radioactive Contaminants Only Required Every Three, Six, or Nine Years per Federal Law
2. BioNeutrals Ygiene(TM) Hospital Grade Achieves a 100% Total Kill (Pass) Against the Life Threatening Clostridium Difficile (C.diff) Spores in Independent EPA Required Protocol Testing.
3. Tengion Provides Business Update and Reports Second Quarter 2011 Financial Results
4. Lexicon to Provide Clinical Pipeline Update and Report Second Quarter 2011 Financial Results
5. BioMarin Provides Update on GALNS Phase 1/2 Extension Study (MOR-100)
6. Medicare HIT Incentive Update for the Oncology Practice - Free Educational Webinar
7. MIT research update: New way to store suns heat
8. Nile Therapeutics Provides Update on Ongoing Phase I Clinical Trial of Cenderitide
9. China-Biotics Provides Update
10. Auxilium Pharmaceuticals, Inc. Updates Launch Progress of XIAPEX® in EU
11. Tengion Provides Business Update and Reports First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... 2015 , ... VetStem Biopharma will be offering weekly private guided tours of ... veterinarians. , The tour and course will be given every Wednesday at 6pm to ... facility. Staff members are welcome to attend with their veterinarian as well. Participants will ...
(Date:7/28/2015)... -- Tauriga Sciences, Inc. (OTCQB:  TAUG) or ("Tauriga" or ... that its stockholders approved an increase in the number ... from 1,000,000,000 to 2,500,000,000 at its Special Meeting of ... Offices of Nixon Peabody LLP in Midtown Manhattan (the ... shares of common stock represented either by proxy or ...
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix Inc. ... 1 clinical trial with MMI-0100, a first-in-class inhibitor ... developed for pulmonary disorders characterized by inflammation and ... United Kingdom , is a double-blind, two-way ... the safety and tolerability of MMI-0100 when given ...
(Date:7/28/2015)... 2015 CSL Behring announced today ... for review the company,s Biologics License Application (BLA) for ... the treatment of hemophilia A. In the pivotal clinical ... Hemophilia A is a congenital bleeding disorder ... affected patients are male. People with hemophilia A may ...
Breaking Biology Technology:VetStem Biopharma weekly veterinary continuing education classes and GMP manufacturing facility tour 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 2Tauriga Sciences, Inc. Stockholders Approve Increase In Authorized Common Stock 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 2U.S. FDA Accepts for Review CSL Behring's Biologics License Application for Its Novel rVIII-SingleChain Therapy for Patients with Hemophilia A 3
... April 20, 2011 European Medical Device Technology ... ( MD+DI ), and Qmed, the world,s only ... announced the keynote and session speakers for the upcoming virtual ... in materials for medical applications . ...
... April 20, 2011 Intrinsic Bioprobes Inc. ("IBI") ... spectrometry-based protein assays for in-vitro diagnostic testing. The ... protein are performed on IBI,s MASSAY® platform at ... accredited diagnostic laboratory of the Institute of Genomics ...
... Today, H. Shep Wild, President and Chief ... biopharmaceutical company focused on the research and development ... provided a company overview to venture capital, pharmaceutical ... Innovation Showcase 2011 hosted by the University of ...
Cached Biology Technology:Keynote Announced for Virtual Event: Developments in Materials for Medical Applications 2Keynote Announced for Virtual Event: Developments in Materials for Medical Applications 3Keynote Announced for Virtual Event: Developments in Materials for Medical Applications 4Keynote Announced for Virtual Event: Developments in Materials for Medical Applications 5Intrinsic Bioprobes Launches Three New CLIA Approved Mass Spectrometry-Based Tests for Proteins Implicated in Kidney Disease and Renal Failure 2CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 2CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 3CureFAKtor Pharmaceuticals Featured at University of Florida Innovation Showcase 2011 4
(Date:6/25/2015)... , June 25, 2015 ... Sensors Market by Type (Swipe & Area), Technology, Material ... Government, Healthcare, Commercial Security & Others) & Geography ... by marketsandmarkets, the said market is expected to ... of 17.1%. Browse 76 market ...
(Date:6/24/2015)... , June 24, 2015 This report provides ... the next six years. It contains an analysis of ... along with their impact from the short, medium, and ... discusses the industry, market, and technology trends that currently, ... need of concerned authorities to efficiently manage the increasing ...
(Date:6/23/2015)...   MedNet Solutions , an innovative SaaS-based ... of clinical research, is pleased to announce that ... company,s intuitive, flexible and affordable cloud-based eClinical technology ... Award by the American Business Awards (SM) ... The American Business Awards are considered the nation,s ...
Breaking Biology News(10 mins):Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... A genome-wide study by researchers at the RIKEN ... General Hospital has identified a genetic variant associated with ... virus carriers. The findings are based on a study ... Nature Genetics . Hepatocellular carcinoma (HCC), the ...
... Scientists from Queen Mary, University of London have ... fish, that could pave the way for furthering our ... and Alzheimer,s. The results will be announced today ... and Supramolecular Chemistry, in Brighton. Zinc is found ...
... July 1, 2011 Tiny marine organisms called zooplankton can ... in areas of the ocean where oxygen levels are so ... into trouble as these areas expand due to climate change. ... survive," said University of Rhode Island doctoral student Leanne Elder. ...
Cached Biology News:Zinc and the zebrafish 2Climate change could turn oxygen-free seas from blessing to curse for zooplankton 2
...
... Speed Rocker, with 12" x 14" table; 115V ... 14" table; 220V. The VSR-50 Variable Speed ... any lab. The VSR-50 provides a rhythmic side-to-side ... gentle to vigourous movement. This makes it ideal ...
...
... a 96-well ELISA-compatible plate (containing 12 x 8-well ... Antibody is immobilized by a method that retains ... tail fiber protein of the T7 bacteriophage. This ... 9 phage per well and low non-specific ...
Biology Products: